ESRC Genomics Network

Seminars

06 July 2009 THeSyS Seminar Series: Interdisciplinarity, partnerships and making bioscience innovations in health work for the poor: what lessons can be shared between the North and the South?

02 December 2008 Human Growth Hormone: Beyond the perils and promise of biomedical enhancement

04 November 2008 Re-writing bodies? Portraiture, the genetics clinic and in/dividual

29 September 2008 Expertise

15 July 2008 Translating research into practice and practice into research in cancer genetics: some implications for the therapeutic misconception

19 June 2008 Intellectual Property Protection for Plant Varieties – An Indian Perspective

14 May 2008 The African Union's Biotechnology Strategy

13 May 2008 Between red and green: placing molecular farming's publics

29 April 2008 What is an Organism?

14 April 2008 Innogen Seminar: "Can big pharma survive new biology?"

10 April 2008 Genomics Forum Seminar - (Re)locating the ‘biosocialities’ of breast cancer genetics; a comparative perspective

02 April 2008 INNOGEN SEMINAR: Papa Andina Initiative: 'Stimulating pro poor innovation within the potato market chain in the Andean region'

04 March 2008 ‘Managing’ biological kinship knowledge - familial and regulatory ‘information-management’ during assisted conception –

26 February 2008 How phenomenology can augment naturalism in medicine

21 February 2008 Genomics as the Limits of the Democratic Imaginary?

19 February 2008 Cell therapy for cardiac disease - medicine of the future?

12 February 2008 Experiments in Collaboration: Social Science, Bioinformatics and the University of California, Santa Cruz Science and Justice Working Group

05 February 2008 'Personal Genomics: The Future of Clinical Genetics?'

31 January 2008 Rethinking the ‘family’ approach: the case of coronary heart disease prevention

31 January 2008 Reconfiguring ‘sciences’: historical perspectives and recent bio-medicine & Making way for molecular biology: implementing, managing, and publicizing reform of biological science at the University of Manchester, 1980-93

15 January 2008 Culture adaptation of human ES cells, self renewal and cancer

08 January 2008 Distributed and Local Explanations in Systems Biology

29 November 2007 Geographies of promissory economy - locating tensions and strains in the bio-economies of stem cell innovation

22 November 2007 Genetic Information in the Medical Context and the Scope of Personal Autonomy in the European Legal Space

07 November 2007 Watchdogs of the Public Interest - the role of science journalists and other science communicators

01 November 2007 Making GM Canola - Making Controversy

09 October 2007 Scenario Planning, Backcasting, and Transition Management for Sustainable Development

08 October 2007 A personal narrative of travels through the Genomic Continent

25 September 2007 Data in context: the vicissitudes of vaccine innovation

14 September 2007 'Getting beyond the usual suspects'

05 July 2007 God Talk in American Public Debates about Genetics: What Does the Public Think?

09 May 2007 'Genetics, gender and an embodied ethics of reproduction'

07 May 2007 Beyond validity and utility: thinking sociologically about the usefulness of genetic tests

01 May 2007 Speaking Precision to Power: Commensuration and Social Policy in the Modern World

27 April 2007 'Methods, tools and approaches: research relationships'

05 April 2007 A framework for using genome wide scanning in drug development: the right drug for the right patient at the right dose

02 April 2007 CoPS revisited: ten years of the ESRC’s Complex Product Systems Innovation Centre

14 March 2007 'The Biomediation of Affect in Cloning Films: Technological Convergence in 'Code 46' and 'Teknolust'

05 March 2007 UK DonorLink Register Two Years on – Using DNA to link adults genetically related through donor conception

05 February 2007 Why are biological objects so hard to define?

07 February 2007 'Metabolic syndrome - Reconstructing 'risk factors' into a medical condition'

05 February 2007 Why are biological objects so hard to define?

24 January 2007 'One nation, one clone? Reflections on cultural and methodological aspects of exploring public attitudes towards new medical technologies'

17 January 2007 'Genetic risks and publics: what are the issues?'

11 January 2007 Assessing Research Use and Research Impact: Developing an Evidence Base for Action

08 January 2007 BiDil, subgroup analyses, and the limits of evidence-based medicine

11 December 2006 Public Views on Biotechnology Applications in China

19 October 2006 Over the Counter Genetic Tests - Regulation in the UK

18 October 2006 Image and Trust?

16 October 2006 Genetics and the Division of Semantic Labour

21 September 2006 Engendering Trust or Engineering Consent? Public Engagement in Recent Biobank Developments

14 September 2006 Is there a Problem with Public Understanding of Genetics?

07 September 2006 The Social Relations of Emergent Genetic Biotechnologies: Control, Surveillance and Exclusion

13 July 2006 Governing Stem Cell Research in California and the USA: Towards a Social Infrastructure

16 June 2006 Expertise and public decision making in the Risk Society - Lessons from the French Experience

07 June 2006 Tangible Affinities? Exploring Real Life Kinship

31 May 2006 Public Trust, Intellectual Property and Human Genetic Databanking

08 May 2006 Patients, Profits and Values: Genzyme and the Creation of Informed Consumers of Potential Innovations

03 April 2006 The Marketing of Genetic Identity

13 March 2006 Cord Blood Banking – new economies of hope and promise in stem cell innovation

08 March 2006 Isolating the ‘farmer’ effect as a component of the advantage of growing genetically modified varieties in developing countries: A Bt cotton case study from Jalgaon - India

16 February 2006 The Diffusion of an Innovative Vaccine Biotechnology : An Examination of Alternative Regulatory Burdens using System Dynamics

14 February 2006 Grappling with a shape-shifter: The APOE Gene and Alzheimer's Disease

25 January 2006 Accommodating risk: women's perceptions of their risks of developing cancer following genetic testing

23 January 2006 Can South Africa lead the biotechnology revolution in Africa

23 January 2006 Transforming Biorisks and the Commercialization of Human Genetic Testing

15 December 2005 Constructing the Moral Arena in Focus Group Discussions about Genetics

15 December 2005 Incorporating Patient Issues into Health Technology Assessment: Implications for Genetic Services

28 November 2005 The global biopolitics and bioethics of human embryonic stem cell science

14 November 2005 Mediating Genomics, Gender and Genre: Travelling Tropes and Global Iconography

21 October 2005 Towards a Bioeconomy? Opportunities and Challenges for Policy

14 October 2005 Emerging and new technologies in developing countries: How regulations and public policy impact on development and innovation

06 October 2005 The development of concepts of inheritance and genetics through childhood and adolescence

10 June 2005 Seminar Series 2005/06

03 June 2005 Seminar by Dr Peter Greenaway

25 May 2005 Public Attitudes towards Genomics: initial findings from the ESRC Attitudes to Genomics Survey

20 May 2005 Engaging the public: knowledge and politics in the governance of new technologies

13 April 2005 Research organisation and research success: responding to rice blast in the Mekong Delta

11 April 2005 Risk-related judgements and decisions about GM food: The role of affect

01 April 2005 Workshop on Clusters and Innovation Processes in Genomics

25 February 2005 Judgment under Siege: The Three-Body Problem of Expert Legitimacy

16 February 2005 Not-me-gov-Risk-and-blame-in-public-sector-information-sharing

01 December 2004 Hierarchy in Organisations: It’s Impact on Innovation, Governance and Stakeholder Interactions

08 November 2004 Public Engagement with Genomics

03 November 2004 The Development of Genomics Capabilities in the Pharmaceutical Industry - an alternative to the revolution model

28 October 2004 Perceived risks, benefits and public deliberation: from ‘GM Nation?’ to Nanotechnology

18 October 2004 Get Beck: In Defence of Risk Analysis

01 September 2004 Classification and Silence

31 August 2004 Cyberinfrastructure for the Ages

14 June 2004 Public databases and privat(ised) property: public perceptions of privacy in relation to human genetic databases

19 May 2004 Categorisation of GM foods: deference, essentialism and perspective

26 April 2004 Collaboration and innovation: the evolution of the UK biotech sector

15 March 2004 Strange bedfellows and usual suspects: mapping the emergent complexity of 'social movement society' engagement with human genetic technologies

16 February 2004 Corporate dominance and agricultural biotechnology: implications for development

14 January 2004 Trading the island laboratory: new geographies of Iceland's genetic heritage

18 December 2003 Coping with the social perception of risk. An overview

20 November 2003 Regulating Biotechnology in the Name of Security

03 November 2003 The work of the BIOS Centre

15 October 2003 The utility of genomic knowledge: patenting and commercialisation

16 September 2003 Experts, Non-experts and the Politics of GM Food

12 June 2003 Do bio-pharmaceuticals offer a therapeutic advance over small chemical drugs?

28 March 2003 Innovation, Growth and Market Structure

27 February 2003 From mousetraps to (onco)mice: the international politics of biotech patents